Physician profile
Daniel Michael Bryan
NPI 1730611625
$6,441.82
in general payments reported to CMS, 2019-2025
19 companies · $166 in 2025
The $166 reported for 2025 was more than what 77% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.37 · 2022: $722 · 2023: $4,330 · 2024: $1,186 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,575 · Travel and Lodging: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,574.57 |
| Travel and Lodging | $1,108.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,694.53 | 2023-2025 | Proclaim, Eterna |
| Medtronic, INC. | $755.22 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Micra |
| Relievant Medsystems, INC. | $390.46 | 2022-2023 | Intracept |
| Nalu Medical, INC. | $378.11 | 2023 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $374.47 | 2022-2023 | Evoke Scs |
| Grt US Holding, INC. | $202.00 | 2022 | |
| Vertos Medical, INC. | $154.16 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $94.45 | 2022-2024 | Intracept, Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $87.65 | 2022-2023 | Ha Minuteman G3-R |
| Nevro Corp. | $81.45 | 2023 | Senza |
| Depuy Synthes Sales INC. | $68.67 | 2023-2024 | Monovisc |
| Si-Bone, INC. | $31.28 | 2023 | |
| Spr Therapeutics, INC | $28.41 | 2023 | Sprint Pns System |
| Camber Spine Technologies LLC | $24.08 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $18.05 | 2023 | Seglentis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $16.10 | 2021 | |
| Redhill Biopharma INC. | $15.93 | 2022 | |
| Forte Bio-Pharma LLC | $15.69 | 2023 | Prolate, Nalocet |
| Interventional Pain Technologies INC. | $11.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.